Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas

Emily B. Lund; Sarah L. Chamlin; Anthony J. Mancini

doi:10.1111/pde.13508

Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas

Emily B. Lund^*, Sarah L. Chamlin, Anthony J. Mancini

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Screening electrocardiography (ECG) before initiation of propranolol for treatment of infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to assess the utility of pretreatment ECG in infants with IH starting propranolol. Although nearly half of the ECGs were abnormal, no contraindications to treatment were identified from screening ECG, and no association was found between any of the reported side effects and abnormal ECG. These results support previously published data, and in a larger cohort, providing further confirmation that pretreatment ECG is not necessary in most infants with IH.

Original language	English (US)
Pages (from-to)	e233-e234
Journal	Pediatric dermatology
Volume	35
Issue number	4
DOIs	https://doi.org/10.1111/pde.13508
State	Published - Jul 1 2018

Keywords

hemangiomas
therapy systemic
vascular tumors

ASJC Scopus subject areas

Dermatology
Pediatrics, Perinatology, and Child Health

Access to Document

10.1111/pde.13508

Cite this

@article{6f270c2754d84ea597c8d84d8a228467,

title = "Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas",

abstract = "Screening electrocardiography (ECG) before initiation of propranolol for treatment of infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to assess the utility of pretreatment ECG in infants with IH starting propranolol. Although nearly half of the ECGs were abnormal, no contraindications to treatment were identified from screening ECG, and no association was found between any of the reported side effects and abnormal ECG. These results support previously published data, and in a larger cohort, providing further confirmation that pretreatment ECG is not necessary in most infants with IH.",

keywords = "hemangiomas, therapy systemic, vascular tumors",

author = "Lund, {Emily B.} and Chamlin, {Sarah L.} and Mancini, {Anthony J.}",

note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2018",

month = jul,

day = "1",

doi = "10.1111/pde.13508",

language = "English (US)",

volume = "35",

pages = "e233--e234",

journal = "Pediatric dermatology",

issn = "0736-8046",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas

AU - Lund, Emily B.

AU - Chamlin, Sarah L.

AU - Mancini, Anthony J.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Screening electrocardiography (ECG) before initiation of propranolol for treatment of infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to assess the utility of pretreatment ECG in infants with IH starting propranolol. Although nearly half of the ECGs were abnormal, no contraindications to treatment were identified from screening ECG, and no association was found between any of the reported side effects and abnormal ECG. These results support previously published data, and in a larger cohort, providing further confirmation that pretreatment ECG is not necessary in most infants with IH.

AB - Screening electrocardiography (ECG) before initiation of propranolol for treatment of infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to assess the utility of pretreatment ECG in infants with IH starting propranolol. Although nearly half of the ECGs were abnormal, no contraindications to treatment were identified from screening ECG, and no association was found between any of the reported side effects and abnormal ECG. These results support previously published data, and in a larger cohort, providing further confirmation that pretreatment ECG is not necessary in most infants with IH.

KW - hemangiomas

KW - therapy systemic

KW - vascular tumors

UR - http://www.scopus.com/inward/record.url?scp=85049664807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049664807&partnerID=8YFLogxK

U2 - 10.1111/pde.13508

DO - 10.1111/pde.13508

M3 - Article

C2 - 29683225

AN - SCOPUS:85049664807

SN - 0736-8046

VL - 35

SP - e233-e234

JO - Pediatric dermatology

JF - Pediatric dermatology

IS - 4

ER -

Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this